Fesoterodine fumarate is the fumarate salt form of fesoterodine, a competitive muscarinic receptor antagonist. It is rapidly hydrolyzed in vivo into an active metabolite that inhibits muscarinic receptors on the bladder detrusor muscle, leading to relaxation of bladder smooth muscle and increased bladder capacity.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 286930-03-8
Fesoterodinyl (4-Hydroxy-tolterodine phenoxy) Ether
pharmaceutical raw material
Oxcarbazepine
pharmaceutical raw material
(3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-yl acetate
pharmaceutical raw material
Suzetrigine Impurity 4
pharmaceutical raw material
Gattex
pharmaceutical raw material
Fesoterodine
pharmaceutical raw material
(E)-but-2-enedioic acid;[2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate
MWHXMIASLKXGBU-RNCYCKTQSA-N
CC(C)C(=O)OC1=C(C=C(C=C1)CO)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2.C(=C/C(=O)O)\C(=O)O